THE USE OF DEFERIPRONE AND METHODS TO TREAT AND/OR PREVENT FRIEDREICH ATAXIA RESULTING FROM INTRACELLULAR MISHANDLING OF IRON

• 收藏
• 分享

专利权人:

MUNNICH, ARNOLD;SPINO, MICHAEL;CABANTCHIK, IOAV

发明人:

MUNNICH, ARNOLD,SPINO, MICHAEL,CABANTCHIK, IOAV

申请号：

MYPI 20083186

公开号：

MY151412A

申请日:

2007.02.21

申请国别(地区):

MY

年份:

2014

代理人:

摘要：

A THERAPEUTICALLY EFFECTIVE AMOUNT OF DEFERIPRONE OR DEFERASIROX OR PHYSIOLOGICALLY ACCEPTABLE SALTS THEREOF FOR THE PREVENTION, STABILIZATION, TREATMENT, OR REVERSAL OF IRON-INDUCED FRDA DISEASE IN PATIENTS RESULTING FROM MITOCHONDRIAL IRON-INDUCED DAMAGE TO PREFERENTIALLY REDUCE THE IRON STORES IN THE MITOCHONDRIA. ALSO FOR THE TREATMENT OF OTHER CONDITIONS AFFECTING THE BRAIN WHERE A KEY ELEMENT IN THE GENERATION OF THE RESULTANT PATHOLOGY IS THE INTRACELLULAR MISHANDLING OF IRON.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/